Apparently it’s Printup the senior director of marketing who is assigned the task to make decisions about Metabical. These decisions about Metabical will decide the fate of the drug. If it is observed closely there are many other stakeholders involved that will eventually decide about the fate of this drug. Printup would decide the marketing and public relation strategies to push the drug in the market. But it’s FDA that’s quite active and concerned after few awful events which occurred from usage of weight reducing drugs. In addition to these events there are some deceptive marketing campaigns. Alli was approved by FDA but still 30 cases of severe levels were caused by Alli. Who is involved in the decision making process? What is the decision making process for Metabical? 1. Who is involved in the decision making process? What is the decision making process for Metabical? 2. How should Printup think about the segmentation of potential Metabical consumers?Who is the optimal target consumer? 3. How should CSP identify and employ the differential advantages that Metabical offers to position itself in the marketplace? 4. Given the position strategy you chose, what would be your communications strategy to eachof your target audiences? Would you change the marketing budget or the IMC mix? If sohow? What would the timeline for your communications plan look like?
2) How should Printup think about the segmentation of potential Metabical consumers? Who is the optimal target consumer? The book of Marketing Management defines “Market Segmentation” as the process of dividing the market into group(s) of similar consumers and selecting the most appropriate to serve. Eventually, the selected group will be called the target market. According to this definition and the case on hand, Printup must decide on the parameters according to which she should start the segmentation process. I suggest using the psychographic segmentation as basis where consumers’ lifestyle is...
Please join StudyMode to read the full document